Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium

Silvia De Sanjose, Yolanda Benavente, Claire M. Vajdic, Eric A. Engels, Lindsay M. Morton, Paige M. Bracci, John J. Spinelli, Tongzhang Zheng, Yawei Zhang, Silvia Franceschi, Renato Talamini, Elizabeth A. Holly, Andrew E. Grulich, James R. Cerhan, Patricia Hartge, Wendy Cozen, Paolo Boffetta, Paul Brennan, Marc Maynadié, Pierluigi CoccoRamon Bosch, Lenka Foretova, Anthony Staines, Nikolaus Becker, Alexandra Nieters

Research output: Contribution to journalArticle

237 Scopus citations

Abstract

Background & Aims: Increasing evidence points towards a role of hepatitis C virus (HCV) infection in causing malignant lymphomas. We pooled case-control study data to provide robust estimates of the risk of non-Hodgkin's lymphoma (NHL) subtypes after HCV infection. Methods: The analysis included 7 member studies from the International Lymphoma Epidemiology Consortium (InterLymph) based in Europe, North America, and Australia. Adult cases of NHL (n = 4784) were diagnosed between 1988 and 2004 and controls (n = 6269) were matched by age, sex, and study center. All studies used third-generation enzyme-linked immunosorbent assays to test for antibodies against HCV in serum samples. Participants who were human immunodeficiency virus positive or were organ-transplant recipients were excluded. Results: HCV infection was detected in 172 NHL cases (3.60%) and in 169 (2.70%) controls (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.40-2.25). In subtype-specific analyses, HCV prevalence was associated with marginal zone lymphoma (OR, 2.47; 95% CI, 1.44-4.23), diffuse large B-cell lymphoma (OR, 2.24; 95% CI, 1.68-2.99), and lymphoplasmacytic lymphoma (OR, 2.57; 95% CI, 1.14-5.79). Notably, risk estimates were not increased for follicular lymphoma (OR, 1.02; 95% CI, 0.65-1.60). Conclusions: These results confirm the association between HCV infection and NHL and specific B-NHL subtypes (diffuse large B-cell lymphoma, marginal zone lymphoma, and lymphoplasmacytic lymphoma).

Original languageEnglish (US)
Pages (from-to)451-458
Number of pages8
JournalClinical Gastroenterology and Hepatology
Volume6
Issue number4
DOIs
StatePublished - Apr 1 2008

    Fingerprint

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

De Sanjose, S., Benavente, Y., Vajdic, C. M., Engels, E. A., Morton, L. M., Bracci, P. M., Spinelli, J. J., Zheng, T., Zhang, Y., Franceschi, S., Talamini, R., Holly, E. A., Grulich, A. E., Cerhan, J. R., Hartge, P., Cozen, W., Boffetta, P., Brennan, P., Maynadié, M., ... Nieters, A. (2008). Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium. Clinical Gastroenterology and Hepatology, 6(4), 451-458. https://doi.org/10.1016/j.cgh.2008.02.011